A 3-day Course for CFS/ME

Sponsor
Norwegian University of Science and Technology (Other)
Overall Status
Recruiting
CT.gov ID
NCT05236465
Collaborator
University of Oslo (Other), Haukeland University Hospital (Other), University of Bristol (Other), Lørenskog municipality (Other), The Research Council of Norway (Other)
100
1
2
48.4
2.1

Study Details

Study Description

Brief Summary

Chronic fatigue syndrome/Myalgic encephalomyelitis (CFS/ME) can be a serious and disabling condition with a heavy symptom burden and low function. Work disability is common, and social life dramatically affected. CFS/ME is a challenging health problem as well as a societal problem.

In recent years, a doubling of the number of patients with a CFS/ME diagnoses has been reported in Norway. The patient group represents a challenge for the health care system, the municipality, and the Norwegian Labour and Welfare Organization (NAV). According to new figures, the NAV pays 100 million Norwegian Kroner (NOK) each month in permanently incapacitated expenses for people with CFS/ME. Municipalities have expenses in form of care, rehabilitation and other measures.

There is a lack of effective treatment for CFS/ME. Evidence-based knowledge is highly needed.

If the 3-day course shows promising effects, this could have positive consequences for patients, relatives and health personnel, but also financially for the society and the municipality.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: A 3-day course
  • Behavioral: Waiting list
N/A

Detailed Description

This is a randomized controlled trial (RCT) to investigate potential effects (positive and negative) of a 3-day course with follow-up for 100 adults with CFS/ME.

The 3-day course used in this trial is named the Lightning Process (LP). The course is built on the LP manual (Parker, 2013) and includes stress theory, Positive Psychology and knowledge about regulating thoughts, feelings and behavior, and through that positively influencing physiology.

Positive and negative effects of the course on symptoms, disability and quality of life will be investigated, and a long-term follow-up of work participation conducted.

Any adverse events experienced during or after the 3-day course will be handled according to protocol.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized Controlled Trial, in which participants are randomly allocated to either the intervention group or to the waiting list control group.Randomized Controlled Trial, in which participants are randomly allocated to either the intervention group or to the waiting list control group.
Masking:
Double (Investigator, Outcomes Assessor)
Masking Description:
The intervention group vs. waiting list control group status will be known to the participants and the personnel delivering the 3-day course. However, the investigator and outcome assessor will be masked to the conditions.
Primary Purpose:
Treatment
Official Title:
A 3-day Course for Adults With Chronic Fatigue Syndrome/Myalgic Encephalopathy (CFS/ME): a Randomized Controlled Trial
Actual Study Start Date :
Mar 21, 2022
Anticipated Primary Completion Date :
Apr 1, 2024
Anticipated Study Completion Date :
Apr 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Experimental: A 3-day course

The course consists of teaching in basic psychology, stress physiology and practice of a specific technique with self-instructions and visualization in a group setting by non-health personnel

Behavioral: A 3-day course
The course is built on the LP manual (Parker, 2013) and includes stress theory, Positive Psychology and knowledge about regulating thoughts, feelings and behavior, and through that positively influencing physiology.

Active Comparator: Waiting list

Treatment as usual (TAU)

Behavioral: Waiting list
Treatment as usual (TAU) in the first 10 weeks. After 10 weeks: Behavioural: A 3-day course. The course is built on the LP manual (Parker, 2013) and includes stress theory, Positive Psychology and knowledge about regulating thoughts, feelings and behavior, and through that positively influencing physiology.

Outcome Measures

Primary Outcome Measures

  1. Physical function [10 weeks after the 3-day course]

    Measured through the Short Form Health Survey (SF-36), physical function, a scale that measures physical function with questions relating to ability to perform physical activity. The instrument contains 10 items with three options on each question. The score range is 0 -100, where 100 is equivalent to no disability.

Secondary Outcome Measures

  1. Fatigue [6 months after the 3-day course]

    Measured through the Chalder Fatigue Questionnaire, an instrument that measures fatigue severity, both on mental and physical fatigue in the last month. The instrument contains 11 items with four different response options in each question. The scale ranges from 0-33, where higher score indicates greater fatigue.

  2. Pain on a daily basis [6 months after the 3-day course]

    Measured through the Brief Pain Inventory, an instrument measuring pain and its allied aspects. The instrument contains 11 items with numeric rating from 0-10, where higher score indicates more severe pain.

  3. Post-Exertional Malaise [6 months after the 3-day course]

    Measured through A Brief Questionnaire to Assess Post-Exertional Malaise, an instrument that measures symptoms after activity. The instrument contains 10 items, with options ranging from 0-4, where a higher score indicates more severity.

  4. Mental wellbeing [6 months after the 3-day course]

    Measured trough the Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS), an instrument that measures mental wellbeing. The instrument contains 14 items, with 5 response categories, summed to provide a single score. Higher score indicates better wellbeing.

  5. Overall improvement [6 months after the 3-day course]

    Measured through the Patient Global Impression of Change (PGIC) with one single item that measures change in function, symptoms and quality of life. The instrument has seven possible options ranging from very much better to very much worse.

  6. Sick leave [24 months after the 3-day course]

    Register data from the Norwegian Labour and Welfare Administration (NAV) on sick leave, benefits, diagnoses from 12 months before the 3-day course and 24 months after the 3-day course.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • CFS/ME diagnosis based on the Canada Consensus Criteria.

  • At least 50% out of school/work.

  • Readiness to change (corresponding to the preparation phase in transtheoretical model)

  • Has given informed consent.

Exclusion Criteria:
  • Assessed by a General Practitioner (GP):

  • Underlying physical illness or mental disorder that may explain the symptoms.

  • Suicide risk/previous suicide attempts.

  • Pregnancy.

  • Bedridden and in need of continuous care.

  • Insufficient Norwegian speaking or writing skills to participate in the 3-day course and fill out questionnaires.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Psychology, NTNU Trondheim Norway

Sponsors and Collaborators

  • Norwegian University of Science and Technology
  • University of Oslo
  • Haukeland University Hospital
  • University of Bristol
  • Lørenskog municipality
  • The Research Council of Norway

Investigators

  • Principal Investigator: Leif Edward Ottesen Kennair, PhD prof, NTNU, Department of Psychology

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Norwegian University of Science and Technology
ClinicalTrials.gov Identifier:
NCT05236465
Other Study ID Numbers:
  • 394844
First Posted:
Feb 11, 2022
Last Update Posted:
Mar 22, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Norwegian University of Science and Technology
Additional relevant MeSH terms:

Study Results

No Results Posted as of Mar 22, 2022